SEC Form 4 · accession 0001437749-16-043294
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David G Kalergis
Officer — Chairman and CEO · Director
Period of report
Dec 8, 2016
Accepted (ET)
Dec 13, 2016 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.74 | Dec 8, 2016 | A | 105,000 | A | — | Dec 8, 2026 | Common Stock | 105,000 | 105,000 | D |
Explanation of responses
- F1The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on November 30, 2019.